Jaa Roberson

Jaa Roberson joined Immunic Therapeutics as Chief People Officer in October 2026. She is a people leader with more than two decades of human resources (HR) experience across the biopharma, health insurance, and retail industries, successfully leading companies through growth, transformation and change by building high performance, diverse and inclusive organizations where everyone thrives, contributes and grows to drive impactful patient and business outcomes.

Most recently as Chief People Officer at Day One Biopharmaceuticals, she guided the organization to scale and grow from 37 to 200 employees while maintaining strong engagement and retention, successfully transition from clinical to commercial stage following the approval and launch of OJEMDA® (pediatric low-grade glioma), expand the pipeline into adult oncology, which included the acquisition of Mersana Therapeutics, and ultimately Day One’s acquisition by Servier. Previously, Ms. Roberson led HR at Bellicum Pharmaceuticals and at Achaogen, where she supported the companies’ expansions, pre-commercial and commercial launch preparations, as well as restructuring and workforce transitions. Earlier in her career, she spent six years at Genentech, a member of the Roche Group, as an HR Business Partner supporting commercial franchises, including the build of the Ocrevus® (MS) and Hemlibra® (hemophilia) franchises. She also held HR leadership roles of increasing responsibility at Blue Shield of California, Levi Strauss & Co. and Williams-Sonoma, Inc.

Ms. Roberson holds a Bachelor of Arts from Rice University and a Master of Music in Violin Performance from the San Francisco Conservatory of Music.